UK markets open in 6 hours 40 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.12 +0.17 (+0.22%) GOLD FUTURES
2,312.40 +2.80 (+0.12%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,144.68 +631.93 (+1.36%)
Aytu BioPharma, Inc. (0A8M.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 06:52PM BST
| Previous close | 2.8100 |
| Open | 0.0000 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 0.0000 - 0.0000 |
| 52-week range | |
| Volume | |
| Avg. volume | 623 |
| Market cap | N/A |
| Beta (5Y monthly) | -1.26 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2024 Earnings Call Transcript
Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2024 Earnings Call Transcript February 14, 2024 Aytu BioPharma, Inc. beats earnings expectations. Reported EPS is $-0.04, expectations were $-0.25. Aytu BioPharma, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to the […]
- Simply Wall St.
Aytu BioPharma Second Quarter 2024 Earnings: Beats Expectations
Aytu BioPharma ( NASDAQ:AYTU ) Second Quarter 2024 Results Key Financial Results Revenue: US$22.9m (down 13% from 2Q...
- Thomson Reuters StreetEvents
Q2 2024 Aytu Biopharma Inc Earnings Call
Q2 2024 Aytu Biopharma Inc Earnings Call
© 2024 Yahoo. All rights reserved.